SEC Form 4 · accession 0001022079-17-000174
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen H Rusckowski
Officer — Chairman, President and CEO · Director
Period of report
Sep 5, 2017
Accepted (ET)
Sep 7, 2017 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 5, 2017 | M | 2,525 | $58.175 | A | 168,413 | D | |
| Common StockF2,F3 | Sep 5, 2017 | S | 2,525 | $108.027 | D | 166,116 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F4 | $58.175 | Sep 5, 2017 | M | 2,525 | D | — | May 1, 2022 | Common Stock | 2,525 | 166,075 | D |
Explanation of responses
- F1This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.
- F2This transaction was executed in multiple trades at prices ranging from $108.00 to $108.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F4The options vested in three annual installments beginning with the first on May 1, 2013, the second on May 1, 2014 and the final on May 1, 2015.